Boothbay Fund Management, LLC Kura Oncology, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $744,192 - $1.4 Million	-45,656 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $319,534 - $756,030	-40,193 Reduced 46.82%	45,656 $744,000
Q1 2020 May 15, 2020	BUY	$6.45 - $14.04 $553,726 - $1.21 Million	85,849 New	85,849 $854,000
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $436,894 - $536,938	-33,685 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $496,853 - $703,005	33,685 New	33,685 $511,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.